103 related articles for article (PubMed ID: 37591750)
1. A prognostic model based on the integrin genes for osteosarcoma.
Zhang J; Cheng Z; Chang X; Wang S
Asian J Surg; 2023 Dec; 46(12):5609-5611. PubMed ID: 37591750
[No Abstract] [Full Text] [Related]
2. Tenascin-C Promotes Tumor Cell Migration and Metastasis through Integrin α9β1-Mediated YAP Inhibition.
Sun Z; Schwenzer A; Rupp T; Murdamoothoo D; Vegliante R; Lefebvre O; Klein A; Hussenet T; Orend G
Cancer Res; 2018 Feb; 78(4):950-961. PubMed ID: 29259017
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of targeting
Tang X; Luo L; Li Y; Wu H; Hu Q; Yue H; He X; Zou J; Min S
Aging (Albany NY); 2020 Dec; 13(1):1212-1235. PubMed ID: 33291071
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
5. IRX1 hypomethylation in osteosarcoma metastasis.
Lu J; Wang J
Oncotarget; 2015 Jul; 6(19):16802-3. PubMed ID: 26158902
[No Abstract] [Full Text] [Related]
6. High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial‑mesenchymal transition in osteosarcoma.
Zeng SX; Cai QC; Guo CH; Zhi LQ; Dai X; Zhang DF; Ma W
Oncol Rep; 2017 Sep; 38(3):1645-1654. PubMed ID: 28731167
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
8. Identification of Prognostic RBPs in Osteosarcoma.
Li B; Fang L; Wang B; Yang Z; Zhao T
Technol Cancer Res Treat; 2021; 20():15330338211004918. PubMed ID: 33754909
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.
Selvarajah GT; Kirpensteijn J; van Wolferen ME; Rao NA; Fieten H; Mol JA
Mol Cancer; 2009 Sep; 8():72. PubMed ID: 19735553
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma.
Wang J; Gong M; Xiong Z; Zhao Y; Xing D
J Orthop Surg Res; 2021 Jul; 16(1):432. PubMed ID: 34225733
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid receptor DNA binding factor 1 expression and osteosarcoma prognosis.
Zhao J; Xu H; He M; Wu Y
Tumour Biol; 2014 Dec; 35(12):12449-58. PubMed ID: 25185653
[TBL] [Abstract][Full Text] [Related]
12. High grade osteosarcoma. Clinico-pathological aspects and molecular prognostic factors.
Tirabosco R
Clin Biochem; 2014 Jun; 47(9):735-6. PubMed ID: 24854682
[No Abstract] [Full Text] [Related]
13. CDC20 and its downstream genes: potential prognosis factors of osteosarcoma.
Wu MS; Ma QY; Liu DD; Li XJ; Deng LJ; Li N; Shen J; Zhao Z; Chen JX
Int J Clin Oncol; 2019 Nov; 24(11):1479-1489. PubMed ID: 31278532
[TBL] [Abstract][Full Text] [Related]
14. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
[TBL] [Abstract][Full Text] [Related]
15. Identification of B cell marker genes based on single-cell sequencing to establish a prognostic model and identify immune infiltration in osteosarcoma.
Zhang Z; Zhang J; Duan Y; Li X; Pan J; Wang G; Shen B
Front Immunol; 2022; 13():1026701. PubMed ID: 36569871
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of elevated ezrin in patients with osteosarcoma.
Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
[TBL] [Abstract][Full Text] [Related]
17. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
Jiang H; Guo W; Yuan S; Song L
Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
[TBL] [Abstract][Full Text] [Related]
18. [Characterization of Cell Subsets Associated With Prognosis of Osteosarcoma Based on Single-Cell Sequencing Data].
Wang ST; Zhu HR; Xu SJ; Gui P; Chen MZ; Li ZX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):773-782. PubMed ID: 37927019
[TBL] [Abstract][Full Text] [Related]
19. Mutations of lysophosphatidic acid receptor genes in human osteosarcoma cells.
Okabe K; Hayashi M; Fujii M; Honoki K; Mori T; Fukushima N; Tsujiuchi T
Pathobiology; 2010; 77(5):278-82. PubMed ID: 21116120
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of NT5DC family-based prognostic model in osteosarcoma.
Chang X; Jiang Y; Wang Z; Lou Z
Asian J Surg; 2024 Jan; 47(1):531-532. PubMed ID: 37777411
[No Abstract] [Full Text] [Related]
[Next] [New Search]
